HEADER MEMBRANE PROTEIN 28-JAN-13 4IY6 TITLE CRYSTAL STRUCTURE OF THE GLUA2 LIGAND-BINDING DOMAIN (S1S2J-L483Y- TITLE 2 N754S) IN COMPLEX WITH GLUTAMATE AND ME-CX516 AT 1.72 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, UNP RESIDUES 413-527, 653-796; COMPND 5 SYNONYM: GLUR-2, AMPA-SELECTIVE GLUTAMATE RECEPTOR 2, GLUR-B, GLUR- COMPND 6 K2, GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2, GLUA2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT, BROWN RAT, RATS; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: GLUR2, GRIA2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ORIGAMI B; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-22B(+) KEYWDS AMPA RECEPTOR LIGAND-BINDING DOMAIN, GLUA2 S1S2J-L483Y-N754S, ME- KEYWDS 2 CX516, ALLOSTERIC MODULATION, MEMBRANE PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR C.KRINTEL,K.FRYDENVANG,K.HARPSOE,M.GAJHEDE,J.S.KASTRUP REVDAT 3 08-NOV-23 4IY6 1 REMARK SEQADV REVDAT 2 23-AUG-17 4IY6 1 SOURCE REMARK REVDAT 1 09-OCT-13 4IY6 0 JRNL AUTH C.KRINTEL,K.HARPSE,L.G.ZACHARIASSEN,D.PETERS,K.FRYDENVANG, JRNL AUTH 2 D.S.PICKERING,M.GAJHEDE,J.S.KASTRUP JRNL TITL STRUCTURAL ANALYSIS OF THE POSITIVE AMPA RECEPTOR MODULATORS JRNL TITL 2 CX516 AND ME-CX516 IN COMPLEX WITH THE GLUA2 LIGAND-BINDING JRNL TITL 3 DOMAIN JRNL REF ACTA CRYSTALLOGR.,SECT.D V. 69 1645 2013 JRNL REFN ISSN 0907-4449 JRNL PMID 23999288 JRNL DOI 10.1107/S0907444913011839 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH C.KRINTEL,K.FRYDENVANG,L.OLSEN,M.T.KRISTENSEN,O.DE BARRIOS, REMARK 1 AUTH 2 P.NAUR,P.FRANCOTTE,B.PIROTTE,M.GAJHEDE,J.S.KASTRUP REMARK 1 TITL THERMODYNAMICS AND STRUCTURAL ANALYSIS OF POSITIVE REMARK 1 TITL 2 ALLOSTERIC MODULATION OF THE IONOTROPIC GLUTAMATE RECEPTOR REMARK 1 TITL 3 GLUA2. REMARK 1 REF BIOCHEM.J. V. 441 173 2012 REMARK 1 REFN ISSN 0264-6021 REMARK 1 PMID 21895609 REMARK 1 DOI 10.1042/BJ20111221 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.JIN,S.CLARK,A.M.WEEKS,J.T.DUDMAN,E.GOUAUX,K.M.PARTIN REMARK 1 TITL MECHANISM OF POSITIVE ALLOSTERIC MODULATORS ACTING ON AMPA REMARK 1 TITL 2 RECEPTORS. REMARK 1 REF J.NEUROSCI. V. 25 9027 2005 REMARK 1 REFN ISSN 0270-6474 REMARK 1 PMID 16192394 REMARK 1 DOI 10.1523/JNEUROSCI.2567-05.2005 REMARK 2 REMARK 2 RESOLUTION. 1.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.68 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.4 REMARK 3 NUMBER OF REFLECTIONS : 33179 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.136 REMARK 3 R VALUE (WORKING SET) : 0.135 REMARK 3 FREE R VALUE : 0.168 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1674 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 23.6822 - 3.9395 0.99 12 151 0.1468 0.1655 REMARK 3 2 3.9395 - 3.1292 1.00 12 161 0.1276 0.1542 REMARK 3 3 3.1292 - 2.7343 1.00 12 135 0.1375 0.1759 REMARK 3 4 2.7343 - 2.4846 1.00 12 138 0.1324 0.1691 REMARK 3 5 2.4846 - 2.3067 1.00 12 160 0.1314 0.1627 REMARK 3 6 2.3067 - 2.1708 1.00 12 145 0.1249 0.1692 REMARK 3 7 2.1708 - 2.0621 1.00 12 148 0.1200 0.1465 REMARK 3 8 2.0621 - 1.9724 1.00 12 141 0.1280 0.1824 REMARK 3 9 1.9724 - 1.8965 1.00 12 138 0.1421 0.1946 REMARK 3 10 1.8965 - 1.8311 1.00 12 110 0.1333 0.1692 REMARK 3 11 1.8311 - 1.7739 1.00 12 132 0.1453 0.1909 REMARK 3 12 1.7739 - 1.7232 0.94 12 115 0.1568 0.2199 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.50 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 17.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.010 NULL REMARK 3 ANGLE : 1.240 NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : 12.700 NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IY6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077357. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-FEB-11 REMARK 200 TEMPERATURE (KELVIN) : 99 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MAX II REMARK 200 BEAMLINE : I911-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.03874 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33234 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.720 REMARK 200 RESOLUTION RANGE LOW (A) : 23.680 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.700 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.12600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3TDJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15.2% PEG 4000, 0.3M LITHIUM SULFATE, REMARK 280 0.1M SODIUM ACETATE, PH 5.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 279K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 32.16500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 50.52000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.16500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 50.52000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4050 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24250 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -54.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 64.33000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MQR A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MQS A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MQS A 303 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GLU A 304 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 305 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 306 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 307 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TDJ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NON-DESENSITIZING FLIP LIKE GLUA2 LIGAND REMARK 900 BINDING CORE MUTANT (S1S2J-L483Y-L754S) IN COMPLEX WITH BPAM-97 AS REMARK 900 WELL AS GLUTAMATE AT 1.95 A RESOLUTION REMARK 900 RELATED ID: 3TDK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE NON-DESENSITIZING FLIP LIKE GLUA2 LIGAND REMARK 900 BINDING CORE MUTANT (S1S2J-L483Y-L754S) IN COMPLEX WITH REMARK 900 CYCLOTHIAZIDE (CTZ) AS WELL AS GLUTAMATE AT 1.45 A RESOLUTION REMARK 900 RELATED ID: 2AL5 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GLUA2 LIGAND BINDING CORE IN COMPLEX WITH REMARK 900 ANIRACETAM AT 1.65 A RESOLUTION. REMARK 900 RELATED ID: 2AL4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE GLUA2 LIGAND BINDING CORE IN COMPLEX WITH REMARK 900 CX614 AT 1.70 A RESOLUTION. REMARK 900 RELATED ID: 4IY5 RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE FUSION PROTEIN OF THE RESIDUES 413-527, LINKER GLY-THR, AND REMARK 999 RESIDUES 653-796 FROM GLUA2 DBREF 4IY6 A 3 117 UNP P19491 GRIA2_RAT 413 527 DBREF 4IY6 A 120 263 UNP P19491 GRIA2_RAT 653 796 SEQADV 4IY6 GLY A 1 UNP P19491 EXPRESSION TAG SEQADV 4IY6 ALA A 2 UNP P19491 EXPRESSION TAG SEQADV 4IY6 TYR A 94 UNP P19491 LEU 504 ENGINEERED MUTATION SEQADV 4IY6 GLY A 118 UNP P19491 LINKER SEQADV 4IY6 THR A 119 UNP P19491 LINKER SEQADV 4IY6 SER A 242 UNP P19491 ASN 775 ENGINEERED MUTATION SEQRES 1 A 263 GLY ALA ASN LYS THR VAL VAL VAL THR THR ILE LEU GLU SEQRES 2 A 263 SER PRO TYR VAL MET MET LYS LYS ASN HIS GLU MET LEU SEQRES 3 A 263 GLU GLY ASN GLU ARG TYR GLU GLY TYR CYS VAL ASP LEU SEQRES 4 A 263 ALA ALA GLU ILE ALA LYS HIS CYS GLY PHE LYS TYR LYS SEQRES 5 A 263 LEU THR ILE VAL GLY ASP GLY LYS TYR GLY ALA ARG ASP SEQRES 6 A 263 ALA ASP THR LYS ILE TRP ASN GLY MET VAL GLY GLU LEU SEQRES 7 A 263 VAL TYR GLY LYS ALA ASP ILE ALA ILE ALA PRO LEU THR SEQRES 8 A 263 ILE THR TYR VAL ARG GLU GLU VAL ILE ASP PHE SER LYS SEQRES 9 A 263 PRO PHE MET SER LEU GLY ILE SER ILE MET ILE LYS LYS SEQRES 10 A 263 GLY THR PRO ILE GLU SER ALA GLU ASP LEU SER LYS GLN SEQRES 11 A 263 THR GLU ILE ALA TYR GLY THR LEU ASP SER GLY SER THR SEQRES 12 A 263 LYS GLU PHE PHE ARG ARG SER LYS ILE ALA VAL PHE ASP SEQRES 13 A 263 LYS MET TRP THR TYR MET ARG SER ALA GLU PRO SER VAL SEQRES 14 A 263 PHE VAL ARG THR THR ALA GLU GLY VAL ALA ARG VAL ARG SEQRES 15 A 263 LYS SER LYS GLY LYS TYR ALA TYR LEU LEU GLU SER THR SEQRES 16 A 263 MET ASN GLU TYR ILE GLU GLN ARG LYS PRO CYS ASP THR SEQRES 17 A 263 MET LYS VAL GLY GLY ASN LEU ASP SER LYS GLY TYR GLY SEQRES 18 A 263 ILE ALA THR PRO LYS GLY SER SER LEU GLY ASN ALA VAL SEQRES 19 A 263 ASN LEU ALA VAL LEU LYS LEU SER GLU GLN GLY LEU LEU SEQRES 20 A 263 ASP LYS LEU LYS ASN LYS TRP TRP TYR ASP LYS GLY GLU SEQRES 21 A 263 CYS GLY SER HET MQR A 301 19 HET MQS A 302 19 HET MQS A 303 19 HET GLU A 304 10 HET GOL A 305 6 HET SO4 A 306 5 HET SO4 A 307 5 HETNAM MQR [(3R)-3-METHYLPIPERIDIN-1-YL](QUINOXALIN-6-YL)METHANONE HETNAM MQS [(3S)-3-METHYLPIPERIDIN-1-YL](QUINOXALIN-6-YL)METHANONE HETNAM GLU GLUTAMIC ACID HETNAM GOL GLYCEROL HETNAM SO4 SULFATE ION HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 MQR C15 H17 N3 O FORMUL 3 MQS 2(C15 H17 N3 O) FORMUL 5 GLU C5 H9 N O4 FORMUL 6 GOL C3 H8 O3 FORMUL 7 SO4 2(O4 S 2-) FORMUL 9 HOH *386(H2 O) HELIX 1 1 ASN A 22 LEU A 26 5 5 HELIX 2 2 GLU A 27 GLU A 30 5 4 HELIX 3 3 GLY A 34 GLY A 48 1 15 HELIX 4 4 ASN A 72 TYR A 80 1 9 HELIX 5 5 THR A 93 GLU A 98 1 6 HELIX 6 6 SER A 123 LYS A 129 1 7 HELIX 7 7 GLY A 141 SER A 150 1 10 HELIX 8 8 ILE A 152 ALA A 165 1 14 HELIX 9 9 THR A 173 SER A 184 1 12 HELIX 10 10 SER A 194 GLN A 202 1 9 HELIX 11 11 LEU A 230 GLN A 244 1 15 HELIX 12 12 GLY A 245 TYR A 256 1 12 SHEET 1 A 3 TYR A 51 ILE A 55 0 SHEET 2 A 3 VAL A 6 THR A 10 1 N VAL A 8 O LYS A 52 SHEET 3 A 3 ILE A 85 ALA A 86 1 O ILE A 85 N THR A 9 SHEET 1 B 2 MET A 18 MET A 19 0 SHEET 2 B 2 TYR A 32 GLU A 33 -1 O GLU A 33 N MET A 18 SHEET 1 C 2 ILE A 100 PHE A 102 0 SHEET 2 C 2 ALA A 223 PRO A 225 -1 O THR A 224 N ASP A 101 SHEET 1 D 2 MET A 107 LEU A 109 0 SHEET 2 D 2 LYS A 218 TYR A 220 -1 O LYS A 218 N LEU A 109 SHEET 1 E 4 ALA A 134 THR A 137 0 SHEET 2 E 4 TYR A 188 GLU A 193 1 O LEU A 191 N GLY A 136 SHEET 3 E 4 ILE A 111 LYS A 116 -1 N MET A 114 O TYR A 190 SHEET 4 E 4 THR A 208 VAL A 211 -1 O MET A 209 N ILE A 115 SSBOND 1 CYS A 206 CYS A 261 1555 1555 2.03 CISPEP 1 SER A 14 PRO A 15 0 -1.97 CISPEP 2 GLU A 166 PRO A 167 0 -3.80 CISPEP 3 LYS A 204 PRO A 205 0 7.45 SITE 1 AC1 7 PRO A 105 MET A 107 SER A 108 SER A 217 SITE 2 AC1 7 LYS A 218 SER A 242 HOH A 471 SITE 1 AC2 9 HIS A 23 GLU A 24 LYS A 129 GLN A 130 SITE 2 AC2 9 THR A 131 ILE A 133 TYR A 161 HOH A 487 SITE 3 AC2 9 HOH A 535 SITE 1 AC3 10 TYR A 80 LYS A 116 LYS A 117 GLY A 118 SITE 2 AC3 10 THR A 119 PRO A 120 LYS A 185 GLY A 186 SITE 3 AC3 10 LYS A 187 HOH A 513 SITE 1 AC4 13 TYR A 61 PRO A 89 LEU A 90 THR A 91 SITE 2 AC4 13 ARG A 96 GLY A 141 SER A 142 THR A 143 SITE 3 AC4 13 GLU A 193 TYR A 220 HOH A 401 HOH A 430 SITE 4 AC4 13 HOH A 457 SITE 1 AC5 4 ARG A 148 TRP A 159 ARG A 163 HOH A 540 SITE 1 AC6 6 SER A 140 LYS A 144 ARG A 148 HOH A 459 SITE 2 AC6 6 HOH A 478 HOH A 649 SITE 1 AC7 5 LYS A 82 LYS A 116 HOH A 586 HOH A 726 SITE 2 AC7 5 HOH A 743 CRYST1 64.330 101.040 47.360 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015545 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009897 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021115 0.00000